Raymond James Financial Services Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.9M | Buy |
|
|||||
|
2024
Q2 | $3.1M | Buy |
|
|||||
|
2024
Q1 | $3.14M | Buy |
|
|||||
|
2023
Q4 | $2.47M | Buy |
|
|||||
|
2023
Q3 | $1.52M | Buy |
|
|||||
|
2023
Q2 | $1.54M | Sell |
|
|||||
|
2023
Q1 | $1.33M | Buy |
|
|||||
|
2022
Q4 | $1.11M | Buy |
|
|||||
|
2022
Q3 | $1.72M | Buy |
|
|||||
|
2022
Q2 | $1.26M | Sell |
|
|||||
|
2022
Q1 | $1.53M | Sell |
|
|||||
|
2021
Q4 | $2.84M | Buy |
|
|||||
|
2021
Q3 | $3.3M | Buy |
|
|||||
|
2021
Q2 | $3.22M | Sell |
|
|||||
|
2021
Q1 | $3.38M | Buy |
|
|||||
|
2020
Q4 | $3.32M | Buy |
|
|||||
|
2020
Q3 | $1.28M | Buy |
|
|||||
|
2020
Q2 | $934K | Buy |
|
|||||
|
2020
Q1 | $459K | Buy |
|
|||||
|
2019
Q4 | $657K | Buy |
|
|||||
|
2019
Q3 | $374K | Buy |
|
|||||
|
2019
Q2 | $400K | Buy |
|
|||||
|
2019
Q1 | $264K | Sell |
|
|||||
|
2018
Q4 | $215K | Sell |
|
|||||
|
2018
Q3 | $577K | Hold |
|
|||||
|
2018
Q2 | $765K | Buy |
|